COMPASS PATHWAYS PLC Debt Conversion, Converted Instrument, Amount
COMPASS PATHWAYS PLC (CMPS) reported Debt Conversion, Converted Instrument, Amount of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-28.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2023-02-28
- COMPASS PATHWAYS PLC debt conversion, converted instrument, amount for the quarter ending 2021-12-31 was $0.00.
- COMPASS PATHWAYS PLC debt conversion, converted instrument, amount for the quarter ending 2021-09-30 was $0.00.
- COMPASS PATHWAYS PLC debt conversion, converted instrument, amount for the quarter ending 2020-12-31 was $0.00.
- COMPASS PATHWAYS PLC debt conversion, converted instrument, amount for the quarter ending 2020-09-30 was $0.00.
- COMPASS PATHWAYS PLC debt conversion, converted instrument, amount for fiscal 2022 was $0.00.
- COMPASS PATHWAYS PLC debt conversion, converted instrument, amount for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- COMPASS PATHWAYS PLC debt conversion, converted instrument, amount for fiscal 2020 was $21.61M.
- COMPASS PATHWAYS PLC debt conversion, converted instrument, amount for fiscal 2019 was $0.00.
| Period end | Debt Conversion, Converted Instrument, Amount 3 month | Debt Conversion, Converted Instrument, Amount 6 month | Debt Conversion, Converted Instrument, Amount 9 month | Debt Conversion, Converted Instrument, Amount 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-02-28 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 6-K 9 month · filed 2023-02-28 | $0.00 derived: sum of 2 quarters · filed 2023-02-28 | $0.00 10-K · filed 2023-02-28 | |
| 2021-09-30 | $0.00 derived: 6-K 9 month − 6-K 6 month · filed 2021-11-09 | $0.00 6-K · filed 2021-11-09 | ||
| 2021-06-30 | $0.00 6-K · filed 2021-08-11 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 6-K 9 month · filed 2023-02-28 | $0.00 derived: sum of 2 quarters · filed 2023-02-28 | $21.61M 10-K · filed 2023-02-28 | |
| 2020-09-30 | $0.00 derived: 6-K 9 month − 6-K 6 month · filed 2021-11-09 | $21.61M 6-K · filed 2021-11-09 | ||
| 2020-06-30 | $21.61M 6-K · filed 2021-08-11 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |